Sophia Ceder
Sophia Ceder
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,
Sofi E Eriksson
Sofi E Eriksson
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,
Ying Yu Liang
Ying Yu Liang
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
2Institute of Molecular and Cellular Biology, A*STAR, Singapore, Singapore
1,2,
Emarndeena H Cheteh
Emarndeena H Cheteh
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,
Si Min Zhang
Si Min Zhang
3Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden
3,
Kenji M Fujihara
Kenji M Fujihara
4Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC Australia
5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC Australia
4,5,
Julie Bianchi
Julie Bianchi
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,
Vladimir J N Bykov
Vladimir J N Bykov
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,
Lars Abrahmsen
Lars Abrahmsen
6Aprea Therapeutics AB, Solna, Sweden
6,
Nicholas J Clemons
Nicholas J Clemons
4Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC Australia
5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC Australia
4,5,
Pär Nordlund
Pär Nordlund
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
2Institute of Molecular and Cellular Biology, A*STAR, Singapore, Singapore
1,2,
Sean G Rudd
Sean G Rudd
3Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden
3,
Klas G Wiman
Klas G Wiman
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
1,✉
1Department of Oncology-Pathology, Karolinska Institutet, BioClinicum J6, Stockholm, Sweden
2Institute of Molecular and Cellular Biology, A*STAR, Singapore, Singapore
3Science For Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden
4Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC Australia
5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC Australia
6Aprea Therapeutics AB, Solna, Sweden
Collection date 2022 Aug.
Subject terms: Cancer therapy, Haematological cancer
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.